SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-13-167300
Filing Date
2013-04-23
Accepted
2013-04-23 16:05:08
Documents
4
Period of Report
2013-06-12
Effectiveness Date
2013-04-23

Document Format Files

Seq Description Document Type Size
1 NOTICE & PROXY STATEMENT d524490ddef14a.htm DEF 14A 593439
2 GRAPHIC g524490g62e19.jpg GRAPHIC 20701
3 GRAPHIC g524490g67p34.jpg GRAPHIC 9632
4 GRAPHIC g524490g68i93.jpg GRAPHIC 5150
  Complete submission text file 0001193125-13-167300.txt   643791
Mailing Address 610N LINCOLN STREET WALTHAM MA 02451
Business Address 610N LINCOLN STREET WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33827 | Film No.: 13776582
SIC: 2835 In Vitro & In Vivo Diagnostic Substances